Vaccine R&D pipeline/IP review is a comprehensive database which allows effective monitoring of the fasting moving vaccine R&D pipeline. The database contains around 450 validated entries of active commercial vaccine programs covering over 80 companies. It can be used for competitive intelligence, business development and strategic planning activities.
In the database, each entry comes with predicted BLA and MAA filing dates along with key details such as clinical trial information, partner details, vaccine composition e.g. adjuvants and predicted market segment(s). New fields for August 2009 are vaccine antigen type and route of administration.
The database also comes with a key findings presentation showing relevant database outputs in graph form and key changes since the last publication. The database is updated approx every 6 months.
DATABASE + PRESENTATION
To order or register for the free "standard version" please contact your region account manager, buy "on-line" or order direct at: Click here>>
*Prices quotes are for global license. Existing holders of database have update price reduced by 50%.
For UK orders VAT will be added at 15.0%.
Please review the TERMS and CONDITIONS of purchase.
